Literature DB >> 8017091

Modification of hepatic drug-metabolizing enzymes in rat fed naturally occurring allyl sulphides.

D Haber1, M H Siess, I de Waziers, P Beaune, M Suschetet.   

Abstract

1. The effects of feeding allyl sulphides to rat (2000 ppm of the diet for 15 days) were investigated on various microsomal hepatic drug-metabolizing enzymes by their immunochemical detection and catalytic activity. 2. Allyl sulphides provoked a temporary dietary restriction, which enhanced the microsomal level of P450 and the activities of NADH-cytochrome c reductase and p-hydroxybiphenyl UDP-glucuronyltransferase (UDPGT 2), and lowered the activities of p-nitrophenol hydroxylase (PNPH), N-nitrosodimethylamine demethylase (NDMAD), laurate omega-hydroxylase (LAH) and glutathione S-transferase (GST). Therefore, pair-fed animals were used as a more relevant control for the dietary effects of allyl sulphides. 3. Diallyl sulphide (DAS) as well as diallyl disulphide (DADS) produced an enhancement of the microsomal level of P4501A2, 2B1/2 and 3A1/2, and epoxide hydrolase (EH) proteins, with an increase in the enzymatic activities they catalyse: ethoxyresorufin O-deethylase (EROD), aryl hydrocarbon hydroxylase (AHH), methoxyresorufin O-demethylase (MROD), ethoxycoumarin O-deethylase (ECOD), pentoxyresorufin O-depentylase (PROD), benzoxyresorufin O-debenzylase (BROD) and EH. Although P4502E1 proteins were lowered on treatment, NDMAD activity was not modified, and PNPH activity was even enhanced by allyl sulphides. Only DAS treatment raised erythromycin N-demethylase (ERDM) activity. 4. Both DAS and DADS increased the activity of GST and p-nitrophenol UDP-glucuronyltransferase (UDPGT 1), whereas UDPGT 2 activity was enhanced only by DAS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8017091     DOI: 10.3109/00498259409043230

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  8 in total

1.  Drug-phytochemical interactions.

Authors:  Costas Ioannides
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

2.  Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers.

Authors:  Keith Gallicano; Brian Foster; Shurjeel Choudhri
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

3.  Protective Effects of Diallyl Sulfide against Thioacetamide-Induced Toxicity: A Possible Role of Cytochrome P450 2E1.

Authors:  Nam Hee Kim; Sangkyu Lee; Mi Jeong Kang; Hye Gwang Jeong; Wonku Kang; Tae Cheon Jeong
Journal:  Biomol Ther (Seoul)       Date:  2014-02       Impact factor: 4.634

4.  Combined Effects of Amino Acids in Garlic and Buna-Shimeji (Hypsizygus marmoreus) on Suppression of CCl4-Induced Hepatic Injury in Rats.

Authors:  Yusuke Yamaguchi; Yushi Hirata; Takeshi Saito; Hitomi Kumagai
Journal:  Foods       Date:  2021-06-27

5.  Odorant metabolism catalyzed by olfactory mucosal enzymes influences peripheral olfactory responses in rats.

Authors:  Nicolas Thiebaud; Stéphanie Veloso Da Silva; Ingrid Jakob; Gilles Sicard; Joëlle Chevalier; Franck Ménétrier; Olivier Berdeaux; Yves Artur; Jean-Marie Heydel; Anne-Marie Le Bon
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

Review 6.  Anticancer Properties of Essential Oils and Other Natural Products.

Authors:  K Blowman; M Magalhães; M F L Lemos; C Cabral; I M Pires
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-25       Impact factor: 2.629

7.  Sulfuric Odor Precursor S-Allyl-l-Cysteine Sulfoxide in Garlic Induces Detoxifying Enzymes and Prevents Hepatic Injury.

Authors:  Yusuke Yamaguchi; Ryosuke Honma; Tomoaki Yazaki; Takeshi Shibuya; Tomoya Sakaguchi; Harumi Uto-Kondo; Hitomi Kumagai
Journal:  Antioxidants (Basel)       Date:  2019-09-10

Review 8.  Herbal bioactivation: the good, the bad and the ugly.

Authors:  Shufeng Zhou; Hwee-Ling Koh; Yihuai Gao; Zhi-yuan Gong; Edmund Jon Deoon Lee
Journal:  Life Sci       Date:  2004-01-09       Impact factor: 5.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.